IGF-1

Quick Summary

• IGF-1 (Insulin-Like Growth Factor 1) is a peptide hormone produced in the liver in response to growth hormone. 🧬
• IGF-1 plays a key role in growth, cell development and anabolic processes throughout the body.
• Athletes and bodybuilders have shown interest in IGF-1 for its potential to increase lean mass and performance.
• However, IGF-1 also promotes fat gain along with muscle gain, and may carry significant health risks.
• IGF-1 is not legal for over-the-counter sale in Australia and requires medical supervision.
• Legal IGF-1 alternatives include natural growth hormone boosters, OKG, Humanofort and lactoferrin-based products.
• Supplements such as Elemental Nutrition HGH are designed to support natural growth hormone pathways, which in turn influence IGF-1 production.
• Using synthetic IGF-1 without medical oversight is risky and associated with serious side effects. ⚠️

Insulin-Like Growth Factor 1 (IGF-1) is a naturally occurring peptide hormone primarily produced in the liver. It plays a central role in childhood growth and continues to influence cellular repair, muscle development, metabolic function and recovery throughout adulthood. Because of its anabolic potential, IGF-1 has captured the attention of athletes and bodybuilders looking for performance-enhancing effects — however, these uses carry risks and legal restrictions.

What Is IGF-1? 🧬

IGF-1, also known as somatomedin C, is produced in response to growth hormone (GH) signalling. Once GH binds to receptors in the liver, it stimulates the release of IGF-1. Structurally similar to insulin, IGF-1 helps regulate cell proliferation, survival, and tissue growth. While IGF-1 is crucial for childhood development, it remains biologically active throughout life, contributing to recovery, adaptation and metabolic regulation.

Why Do People Use IGF-1? 💪

In clinical settings, synthetic IGF-1 analogues have been studied for treating growth disorders, GH insensitivity and related medical conditions. Outside medical environments, interest in IGF-1 is driven by its anabolic properties, including its potential influence on:

• Muscle protein synthesis
• Cell regeneration
• Strength and hypertrophy
• Exercise recovery

While IGF-1 is sometimes discussed in the bodybuilding community, using synthetic IGF-1 for performance enhancement is illegal and risky. Its effects are not limited to lean tissue — IGF-1 also promotes fat storage, making its outcomes unpredictable and often undesirable without medical oversight.

IGF-1 Negatives & Side Effects ⚠️

The drawbacks and potential dangers of synthetic IGF-1 use are well documented in clinical literature. Reported concerns include:

1. Fat Mass Gain

IGF-1 does not exclusively target muscle tissue. Studies show that increases in IGF-1 can stimulate both muscle and fat cell growth.

2. Short-Term Side Effects

Clinical trials have reported temporary adverse reactions in a large proportion of subjects, including:

• Headache
• Vomiting
• Hypoglycaemia (dangerously low blood sugar)

3. Long-Term Health Risks

Extended use of recombinant IGF-1 can lead to tolerance due to the development of anti-IGF-1 antibodies, requiring increasingly higher doses. Additionally, its role in cellular proliferation raises concerns about increasing cancer risk in predisposed individuals. Experts recommend extreme caution when considering IGF-1 therapy.

IGF-1 Legal Status in Australia 🚫

IGF-1 is a controlled substance in Australia. It is:

• Not legal for sale over the counter
• Only available via medical prescription for very specific conditions
• Illegal to purchase, possess, or use without medical supervision

These laws exist due to the significant side effects and risks associated with misuse.

Legal IGF-1 Alternatives ✔️

For those looking to naturally support the body’s IGF-1 pathways without breaking the law, several safe and legal options exist. These supplements are not synthetic hormones — instead, they support natural physiological processes linked to recovery, growth hormone release and anabolic signalling.

1. Ornithine Alpha-Ketoglutarate (OKG)

OKG is a popular ingredient in pre-workouts and intra-workout formulas and may support natural IGF-1 signalling as part of its broader role in recovery and nitrogen balance. It is fully legal and widely available.

2. Humanofort

Humanofort contains embryonic peptides that exhibit IGF-1–like activity. While research suggests it may modulate anabolic pathways, some studies indicate it may slightly reduce natural IGF-1 levels in certain individuals. More research is needed, but it remains a popular legal option.

3. Natural Growth Hormone (GH) Support Supplements

GH boosters often contain amino acids, botanicals and bioactive compounds that support the body's own growth hormone release. Since GH stimulates natural IGF-1 production, this approach is often more reliable than IGF-1–focused supplements and remains fully legal.

4. Lactoferrin-Based & Hormone Support Products

Lactoferrin has been investigated for its potential to support IGF-1 activity and anabolic signalling. Supplements designed to support normal GH pathways and recovery – such as Elemental Nutrition HGH – are formulated to work with the body’s own hormone systems rather than replacing them with synthetic compounds.

These alternatives are legal in Australia and provide options for individuals aiming to support recovery, performance and muscle development more safely.

FAQs About IGF-1 ❓

References

• Balhara et al. Recombinant Human IGF-1 Therapy: Where Do We Stand Today? Indian J Pediatr. 2012;79:244-249.
• Chernausek et al. Long-term treatment with recombinant IGF-1 in children with severe IGF-1 deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab. 2007;92:902-910.
• Midyett et al. Recombinant IGF-1 treatment in short children with low IGF-1 levels: first-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2010;95:611-619.
• Mihaescu et al. Significant modification of lipid metabolism in aged persons following treatment with a nutritive supplement containing embryonary peptides – preliminary results. Rom J Intern Med. 2005;43:133-139.